Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For HLFFF
Valuation Weak
14%
Profitability n.A.
Fin. Growth Positive
67%
Leverage & Liquidity Weak
33%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
1 Financial Health
Metric Q4 Q1 Δ in %
Current Ratio -10.05 0.81 0.90
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 3164.70 -103.95 3.18
Naive Interpretation member
2 Per Share
Metric Q4 Q1 Δ in %
Book Value -8.04 5.49 5.97
Cash -14.12 2.29 2.66
Capex 40.83 -0.24 -0.41
Free Cash Flow -80.75 -0.04 0.20
Revenue 12.40 12.21 10.86
Naive Interpretation member
3 Profitability
Metric Q4 Q1 Δ in %
Gross Margin 2.56 0.62 0.61
Operating Margin 288.37 -0.04 0.01
ROA -723.90 -0.03 < 0.005
ROE -743.45 -0.09 -0.01
ROIC -439.42 -0.07 -0.01
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of HLFFF is permitted for members.
5 Growth
The "Growth Entry" for the Focus of HLFFF is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of HLFFF is permitted for members.